Agents, such as anesthetics, are often administered to patients through a breathing system to the patient's lungs. Such agents are sometimes provided in a liquid form which is vaporized in a medical vaporizer and transported by a carrier gas to the patient's lungs. Existing vaporization systems are costly, occupy significant space, require significant heat input and suffer from slow turn on/turn off response time.
Flow passage 24 comprises a conduit, channel, pipe, plenum or other structure adapted to be connected to flow source 50 and through which a carrier gas provided by flow source 50 may flow on its way to patient breathing apparatus 80.
Porous vaporization element (PVE) 30 comprises a porous member or structure having a plurality of interconnected voids, cells, or pores, formed by a latticework of distributed base material that the element is made of, through which gas and liquid may flow or pass. The voids of porous vaporization element 30 are sized to present an acceptable flow restriction to gas flow and to preclude liquidation from obstructing gas flow through porous vaporization element 30 while, at the same time, facilitating evaporation of the liquid agent upon the latticework surfaces of porous vaporization element 30. In one implementation, the size of such voids is in a range of between 30 and 60 pores per inch. In one implementation, the interconnected voids of porous vaporization element 30 are sized and spaced to further facilitate distribution of liquid agents, such as liquid anesthetics, across the latticework surfaces bounding such voids through capillary action. The porous vaporization element 30 is chosen to have a relative density to facilitate evaporation of the liquid agent upon the latticework surfaces of porous vaporization element 30. In one implementation, the relative density of such porous vaporization element is in a range of between 2 and 15%. The base material comprising the latticework of porous vaporization element 30 is chosen to have a thermal conductivity to facilitate evaporation of the liquid agent upon the latticework surfaces of porous vaporization element 30. In one implementation, the thermal conductivity of such base material is in a range of between 2 and 20 W(m)−1(° C.)−1.
Examples of porous vaporization element 30 include, but are not limited to, reticulated metallic or nonmetallic foams, porous plastics, metallic or nonmetallic grids, matrices or screens, or fused or at least partially interwoven and interconnected strands or fibers. In one implementation, porous vaporization element 30 is three-dimensional, having multiple interconnected voids extending in all three orthogonal axes. In other implementations, porous vaporization element 30 may be two-dimensional, having multiple interconnected voids extending in first and second orthogonal axes, wherein gas and liquid are permitted to pass through porous vaporization element 30 in a direction through the third axis.
In one implementation, the base material forming the latticework of porous vaporization element 30 has an affinity for, or is philic with respect to a liquid agent, such as a liquid anesthetic, to be dispersed by dispersion mechanism 34. In other words, the latticework surfaces bounding each of the voids are formed from one or more materials that interact with the liquid agent to attract and spread liquid agent over itself. As a result, liquid agents naturally flow across and within porous vaporization element 30 to increase the overall surface area along which the liquid agent is exposed to carrier gas flow for vaporization. Examples of materials having an affinity to liquid agents or which are philic to liquid agents, such as liquid anesthetics, include, but are not limited to, ceramics, Aluminum, Copper, Inconel, Nickel, Tin, Zinc, Carbon, Silicon Carbide, Silicon Nitride, Polyurethane, Polyether, or Polyester.
In one implementation, the base material forming the latticework of porous vaporization element 30 are resistant to degradation resulting from contact with liquid agents to be dispersed by dispersion mechanism 34, such as liquid anesthetics. Such materials are further resistant to the emission of bio-hazardous components when exposed to material or chemicals of the liquid agents, such as anesthetic compounds. Examples of such materials include, but are not limited to, ceramics, Aluminum, Copper, Inconel, Nickel, Tin, Zinc, Carbon, Silicon Carbide, Silicon Nitride, Polyurethane, Polyether, or Polyester .
In one implementation, the base materials forming or comprising the latticework are solid. In another implementation, the base materials forming the latticework may be hollow, porous or tubular. For example, the lattices of the latticework may themselves be formed from hollow, tubular or porous strands, bands or links of material. In some implementations, the base materials forming the latticework may or may not have the above noted properties, but may be coated with one or more other materials having the aforementioned properties relating to agent affinity, degradation resistance and thermal or electrical conductivity.
As schematically shown in
Because porous vaporization element 30 extends across at least a majority of a cross-sectional area of flow passage 24, and nominally across the entire cross-sectional area of flow passage 24, carrier gas from flow source 50 is more likely to flow through porous vaporization element 30 rather than passing porous vaporization element 30 by flowing around, across the surface of, or only through a limited depth of voids of, porous vaporization element 30. Consequently, the interaction between porous vaporization element 30, liquid agent applied to porous vaporization element 30 and the carrier gas flowing through porous vaporization element 30 is enhanced or maximized. As a result, the overall efficiency of vaporizer 22 and vaporization of liquid agent is enhanced. In addition, because liquid agent is more efficiently and more rapidly vaporizing carried away by the greater airflow flowing through porous vaporization element 30, liquid agent is less likely to pool or collect, providing vaporizer 22 with a better response time (initiating the supply of a vaporized agent or discontinuing the supply vaporized agent more rapidly in response to vaporizer 22 being turned on or turned off, respectively).
Dispersion mechanism 34 comprises a device configured to distribute or disperse liquid agent or agents onto one or more of the outer faces or within porous vaporization element 30. Examples of devices that may be used to disperse liquid agents include, but are not limited to, liquid diaphragm, gear, piston, syringe, or peristaltic pumps, and liquid injection or dispensing valves. In one implementation, dispersion mechanism 34 may include a nozzle 35 through which liquid agent, such as liquid anesthetics, are sprayed onto one or more outer faces of porous vaporization element 30. In one implementation, such liquid agents are sprayed onto an upstream face 32 of porous vaporization element 30 (upstream being defined with respect to the direction of the flow of carrier gas from flow source 50 through porous vaporization element 30). As a result, the direction of the carrier gas flow from flow source 50 further assists in distributing the liquid agent onto the external face and internal substructure surfaces of the porous vaporization element 30. By spreading the liquid agent across a larger surface area, vaporization efficiency is enhanced.
In one implementation, dispersion mechanism 34 is configured to spray or mist droplets of a size such that the droplets are sufficiently small to form a relatively thin layer of continuous or spaced apart droplets on surfaces of porous vaporization element 34 providing efficient surface area coverage and vaporization. At the same time, the droplets are sized sufficiently large to inhibit the droplets from being carried by the carrier gas completely through the porous vaporization element 30 without becoming deposited upon the surfaces of porous vaporization element 30 and without being vaporized. In one implementation, dispersion mechanism 34 is configured to spray or mist droplets of a diameter between 10 μm and 5 mm, nominally of a diameter between 100 μm and 300 μm. In other implementations, dispersion mechanism 34 may spray or mist droplets of different sizes.
In some implementations, dispersion mechanism 34 may include multiple nozzles configured to spray or mist droplets of different sizes. For example, a first nozzle may emit droplets of a first size up on a first portion of porous vaporization element 30 while a second nozzle emit droplets of a second size upon a second portion of porous vaporization element 30. The size of such droplets sprayed onto the different portions of porous vaporization element 30 may be varied based upon differing carrier gas flow characteristics through the different portions of the poorest vaporization element 30. For example, portions having a higher carrier glass flow may receive larger droplets as compared to portions having a lower carrier gas flow.
In some implementations, the size of the droplets may change over time. For example, depending upon the sensed feedback regarding the amount of liquid agent being vaporized (the efficiency of agent vaporization), dispersion mechanism 34 may adjust the size of the droplets being sprayed or misted to enhance vaporization efficiency. In some circumstances, it may be desirable to increase or decrease the rate of vaporization depending upon a patient's needs. In some implementations, such an adjustment may be made by changing the nozzle openings to change a size of the droplets being sprayed onto porous vaporization element 30. During startup or just prior to shut down of vaporizer 22, the size of the droplets may be changed to effectuate a quicker startup or to reduce continuing vaporization of the agent after shutdown of vaporizer 22. In some implementations, the size of the droplets sprayed by mechanism 34 may be adjusted based upon or in response to sensed or input flow characteristics (pressure, velocity etc.) of the carrier gas from flow source 50.
Because the liquid agent is sprayed or misted onto porous vaporization element 30, rather than being wicked through or onto the surfaces of porous vaporization element 30, vaporizer 22 has a much quicker turn on-turn off response time. When vaporizer 22 is to be turned off or deactivated, dispersion mechanism 34 may be turned off. Because the liquid agent is sprayed or misted onto porous vaporization element 30, there is little if any collection or pooling of liquid agent that must still be evaporated or vaporized after dispersion mechanism 34 is turned off. Any remaining liquid agent after such shutdown is dispersed or spread over large surface areas for quick dissipation. In contrast to systems that utilize wicking, there is little or no liquid agent captured in the wicking material that must be vaporized even after porous vaporization element 30 has been shut down.
As schematically shown in
In yet another implementation, as shown by
Flow source 50 comprises one or more devices configured to supply and direct a flow of a carrier gas through porous vaporization element 30 in the direction indicated by arrow 52 such that the carrier gas flows from an upstream face 32 and exits opposite through a downstream face 37. In one implementation, flow source 50 is configured to supply a selected one or a mixture of multiple carrier gases such as air, carbon dioxide, Heliox, nitrous oxide or oxygen. In one implementation, flow source 50 moves in the direction indicated by arrow 52. In another implementation, flow source 50 may move gas across porous vaporization element 30 by drawing carrier gases through porous vaporization element 30.
Patient breathing apparatus 80 comprises a mechanism by which the carrier gas and the liquid agent that is vaporized and is being carried by the carrier gas may be supplied to a patient's lungs. In one implementation, breathing apparatus 80 may comprise a respirator with a full or partial face piece or mask. One implementation, breathing apparatus may comprise a mask such as a nasal mask or a nasal hood. In other implementations, routing apparatus 80 may have other configurations.
In one example method, the liquid agent comprises a liquid anesthetic. Examples of liquid anesthetics include, but are not limited to, desflurane (DES), enflurane (ENF), halothane (HAL), isoflurane (ISO) and sevoflurane (SEV). In other implementations, other anesthetics or other agents having other functions may be dispersed and vaporized by system 20 for inhalation by a patient.
As indicated by step 104, flow source 50 directs a carrier gas through porous vaporization element 30 so as to vaporize liquid agent from latticework surfaces of porous vaporization element 30. In one example, a flow of a carrier gas is directed through porous vaporization element 30 in the direction indicated by arrow 52 such that the carrier gas flows from an upstream face 32 and exits opposite through a downstream face 37. In other implementations, flow source 50 may direct carrier gases from one or more side faces 38 of porous vaporization element 30, wherein gas flow is turned prior to exiting the porous vaporization element 30. In one implementation, flow source 50 supplies a selected one or a mixture of multiple carrier gases such as air, carbon dioxide, Heliox, nitrous oxide or oxygen. In one implementation, flow source 50 moves gas in the direction indicated by arrow 52. In another implementation, flow source 50 may move gas across porous vaporization element 30 by drawing carrier gases through porous vaporization element 30.
As indicated by step 106, carrier gas and the liquid agent that has been vaporized leave porous vaporization element 30 and are passed or directed to patient breathing apparatus 80. As a result, the liquid agent, such as anesthesia, may be inhaled by the patient.
Overall, vaporization system 20 provides a relatively large surface area (the total of the latticework surface area of each of the voids, cells, or pores) upon which the liquid agent may spread and be supported as the carrier gases from flow source 50 flow through the porous vaporization element. This large surface area enhances vaporization efficiency without increasing cost as porous vaporization element 30 may comprise an element, such as a reticulated foam, that is relatively inexpensive. At the same time, large surface area is provided without increasing the overall size of vaporization element 30, permitting vaporization element 30 to be compact. The enhanced vaporization efficiency further allows power consumption to be reduced or battery life to be increased. Because of the denser, larger surface area, higher temperatures otherwise utilized to vaporize the liquid agent may also be reduced, reducing or eliminating the risk of anesthetic decomposition due to the heat and extending battery life or reducing power consumption.
Heater 240 comprises one or mechanisms by which energy is generated and transferred to porous vaporization element 30. In particular, during evaporation of the liquid agent upon the latticework surfaces of porous vaporization element 30, energy or heat is extracted. Heater 240 supplies an amount of energy or heat to replace the energy lost during evaporation. As a result, heater 240 assists in maintaining evaporation rates or performance of system 220. In some implementations, heater 240 may be omitted depending upon the ambient temperature or other factors.
In step 305, the porous vaporization element 30 is heated using heater 240. In one implementation, heat may be generated external to porous vaporization element 30 and thermally conducted through or across porous vaporization element 30. In one implementation, portions of porous vaporization element 30 are formed from one or more materials which have a high degree of thermal conductivity such as metals. In such implementations, the heat generator of heater 240 may be in thermal contact with a face 32, 37, 38 of porous vaporization element 30. In other implementations, porous vaporization element 30 may include electrically resistive materials, wherein heater 240 supplies electrical current across the electrically resistive materials to generate heat within and throughout the porous vaporization element 30, itself. In one implementation, porous vaporization element 30 may comprise tubes or conduits through which a heated medium is passed. As noted above, the heating of the porous vaporization element 30 replaces energy lost during vaporization to maintain vaporizer performance.
Porous vaporization element 30, dispersion mechanism 34 and heater 240 are each described above with respect to vaporization systems 20 and 220. Agent supply 436 supplies one or more liquid agents, such as one or more different types of anesthetics, to dispersion mechanism 34 for dispersion to porous vaporization element 30. Examples of the one or more agents that may be supplied by supply 436 include, but are not limited to, desflurane (DES), enflurane (ENF), halothane (HAL), isoflurane (ISO) and sevoflurane (SEV). In one implementation, agent supply 436 may include one or more valves providing a caretaker with an option of selectively delivering a particular type of agent or anesthetic to dispersion mechanism 34. In one implementation, such selection may be made in response to control signals from controller 428. In other implementations, an agent supply 436 may be dedicated to a single agent or liquid anesthetic.
Agent sensor 438 comprises one or more sensing devices configured to sense an amount of agent either within porous vaporization element 30 or being carried by the carrier gas after the carrier gas has exited porous vaporization element 30. Signals from agent sensor 438 are communicated to controller 428 for controlling or adjusting dispersion of liquid agent onto porous vaporization element 30 by dispersion mechanism 34. For example, in response to sensed amounts of agent from agent sensor 438, controller 428 may adjust one or both of the dispersion area or pattern as well as the dispersion rate of dispersion mechanism 34. Such adjustments may be made to increase or decrease the amount of agent within the carrier gas produced by vaporization system 420 or to increase vaporization efficiency.
Porous vaporization element temperature sensor 242 comprises one or more sensing devices or sensing elements configured and located to sense temperatures of porous vaporization element 30. Porous vaporization element temperature sensor 242 produces signals indicating such sensed temperatures, wherein the signals are transmitted to controller 428. Controller 428 utilizes such signals to control and adjust the supply of energy to porous vaporization element 30 by heater 240. Such adjustments to the operation of heater 240 may be utilized to maintain a desired or optimum temperature of porous vaporization element 30 and to inhibit such temperatures from reaching a point where the composition of the agent, such as an anesthetic, occurs. Such adjustments enable vaporization system 420 to automatically adjust and respond to changes in ambient temperature, changes in thermal conductivity or changes in heat delivery or conduction over time to maintain reliable and consistent performance of vaporization system 420.
Flow source 450 is similar to flow source 50 in that flow source 450 supplies a flow of carrier gas through porous vaporization element 30. In one example, a flow of a carrier gas is directed through porous vaporization element 30 in the direction indicated by arrow 52 such that the carrier gas flows from an upstream face 32 and exits through an opposite downstream face 37. In other implementations, flow source 450 may direct carrier gases from one or more side faces 38 of porous vaporization element 30, wherein airflow is turned prior to exiting the porous vaporization element 30. In one implementation, flow source 450 supplies a selected one or a mixture of multiple carrier gases. In one implementation, flow source 450 moves gas in the direction indicated by arrow 52. In another implementation, flow source 50 may move gas across porous vaporization element 30 by drawing carrier gases through porous vaporization element 30.
In the particular example implementation illustrated, flow source 450 comprises carrier gas supplies 454A, 454B, 454C and 454D (collectively referred to as supplies 454) and mixer 456. Supplies 454 supply various carrier gases to mixer 456. Mixer 456 selectively mixes gases received from supplies 454. In one implementation, mixer 456 comprises valves for selectively drawing gases from supplies 454 to produce a mixture to serve as a carrier gas for vaporization system 420. In one implementation, such valves may be selectively open and closed in response to control signals from controller 428. In the example implementation illustrated, supplies 454 supply carrier gases such as oxygen, nitrous oxide, air and carbon dioxide. In other implementations, supplies 454 may supply other or additional carrier gases for carrying one or more agents from agent supply 436.
Breathing system 424, also referred to as a breathing or patient circuit or respiratory circuit, supplies one or more gases to patient's lungs 82 through breathing apparatus 80. Breathing system 424 conveys the carrier gas and one or more agents, such as anesthetic gases or vapors, provided by vaporization system 420 to the patient's lungs 82 while removing waste and agent gases from the patient's lungs 82. Breathing system 424 comprises carbon dioxide scavenger 468, ventilator 470, bellows assembly 472, and one-way valves 476, 478, 480 and breathing apparatus 80.
Carbon dioxide scavenger 468 comprises an absorber configured to remove or filter carbon dioxide, other gases, or compounds from gas exhaled by the patient prior to recycling such gases back into the breathing circuit. In one implementation, carbon dioxide scavenger 468 comprises a filter formed from carbon dioxide absorbent material such as soda lime. In other implementations where exhausted or exhaled gas is not recycled, carbon dioxide scavenger 468 may be omitted.
Ventilator 470 provides gas to the patient during an inhalation cycle. In the example illustrated, ventilator 470 selectively supplies and withdraws pressurized air to and from an exterior of bellows 484 of bellows assembly 472. During inhalation, ventilator 470 supplies gas are air to the exterior of bellows 484, collapsing bellows 484 to force gas within bellows 484 through carbon dioxide scavenger 468 (in the direction indicated by arrow 485), through valve 478 (in the direction indicated by arrow 486) where the gas flow picks up the carrier gas and vaporized agents from vaporization system 420, and through valve 480 (in the direction indicated by arrow 488) to the breathing apparatus 80 and the patient's lungs 82. During exhalation, expelled gas from the patient's lungs 82 passes through valve 476 in the direction indicated by arrow 490 to fill the bellows 484. In some implementations, breathing system 424 may alternatively be configured to be utilized with the patient being “bagged”, wherein the patient is carrying out spontaneous breathing but is connected to the breathing system 424 absent or disconnected from ventilator 470 and bellows assembly 472.
Input 426 comprises one or more devices by which commands or selections may be input or otherwise provided to controller 428. Examples of input 426 include, but are not limited to, a keypad, touch pad, keyboard, touchscreen, microphone and speech recognition software, switches, buttons and the like.
Controller 428 comprises one or more processing units configured to receive sensed values, data or signals from various components of delivery system 400 such as agent sensor 438 and porous vaporization element temperature sensor 242 as well as from other sensors sensing physical conditions of the patient receiving gas from delivery system 400. Controller 428 is further configured to generate control signals based inputs or commands received via input 426 and based upon such sensed signals or values controlling the operation of a display 436, dispersion mechanism 34, heater 240 and mixer 456. Controller 428 may generate control signals directing operation of other components of delivery system 400 as well.
For purposes of this application, the term “processing unit” shall mean a presently developed or future developed processing unit that executes sequences of instructions contained in a memory. Execution of the sequences of instructions causes the processing unit to perform steps such as generating control signals. The instructions may be loaded in a random access memory (RAM) for execution by the processing unit from a read only memory (ROM), a mass storage device, or some other persistent storage. In other embodiments, hard wired circuitry may be used in place of or in combination with software instructions to implement the functions described. For example, controller 428 may be embodied as part of one or more application-specific integrated circuits (ASICs). Unless otherwise specifically noted, the controller 428 is not limited to any specific combination of hardware circuitry and software, nor to any particular source for the instructions executed by the processing unit.
As with vaporization system 20, vaporization system 420 provides for vaporization of liquid agents in a more compact, less expensive, more efficient, and more reliable manner. As with vaporization system 220, vaporization system 420 enhances vaporization performance by heating the porous vaporization element 30. Although vaporization system 420 is illustrated as being utilized with the specific breathing system 424, in other implementations, vaporization system 420 may be utilized with other breathing systems 424.
Heater 540 extends adjacent and in contact with upstream face 32 of porous vaporization element 530 so as to conduct heat to element 530 while also allowing carrier gases to be directed through heater 540 and subsequently through porous vaporization element 530. In one implementation, the heater 540 has openings 544 so not to overly resist gas flow. In one implementation, the heater 540 is formed from materials such as
Stainless Steel, Copper, Iconel, Nickel, Nichrome, Phosphor-Bronze, or Brass wire mesh and has interconnected openings 544 having density of between 4 and 100 openings per inch. Although illustrated as comprising multiple layers of openings 544 in the direction of arrow 52, in other implementations, heater 540 may comprise a single layer of an array of openings 544. Although heater 540 is illustrated as being on upstream face 32 of porous vaporization element 530 such that the carrier gases transfer heat into porous vaporization element 530 as well as the dispersed liquid agents, in other implementations, heater 540 may be in contact with other faces of porous vaporization element 530.
Holder 1002 is operably located between flow source 50, 450 and patient breathing apparatus 80. Holder 1002 removably suspends and retains cartridge 1004 across a flow path of carrier gases from flow source 50, 450. In one implementation, holder 1002 supports cartridge 1004 in a plane substantially perpendicular to the carrier gas flow direction 52. While supporting cartridge 1004, holder 1002 does not substantially interfere with the flow of carrier gases through cartridge 1004. In the example illustrated, holder 1002 comprises a shelf underlying the outer peripheral portion of cartridge 1004 to support cartridge 1004. As a result, cartridge 1004 may be simply slid along the shelf of holder 1002 into and out of position without use of tools and without permanent destruction or deformation of holder 1002 or cartridge 1004. In other implementations, holder 1002 may comprise continuous or spaced grooves, channels, tracks, clips, hooks or other releasable mounting or retaining mechanisms.
Cartridge 1004 comprises a self-contained unit or member configured to be removably retained across a carrier gas flow by holder 1002. As shown in
In use, the system employing arrangement 1000 may include a door 1008 which may be opened and closed to allow insertion or withdrawal of cartridge 1004. In implementations where a heater is utilized to heat porous vaporization element 30, insertion of cartridge 1004 into engagement or connection with retainer or holder 1002 also results in connection of porous vaporization element 30 to the external portions utilized for the heating of porous vaporization element 30. For example, in one implementation in which heater 240 comprises a heating device similar to heater 940, insertion of cartridge 1004 into chamber 1010 (in the direction indicated by arrows 1012) may bring the electrically resistive portions of porous vaporization element 30 into electrical connection with voltage source 945 (described above with respect to
Although the present disclosure has been described with reference to example embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the claimed subject matter. For example, although different example embodiments may have been described as including one or more features providing one or more benefits, it is contemplated that the described features may be interchanged with one another or alternatively be combined with one another in the described example embodiments or in other alternative embodiments. Because the technology of the present disclosure is relatively complex, not all changes in the technology are foreseeable. The present disclosure described with reference to the example embodiments and set forth in the following claims is manifestly intended to be as broad as possible. For example, unless specifically otherwise noted, the claims reciting a single particular element also encompass a plurality of such particular elements.